Creating Value by Overcoming Treatment Barriers View previous quarters - Today Latest News View all press releases 09.01.26 Aquestive Therapeutics to Participate in Upcoming September Investor Conferences Read More 08.11.26 Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update Read More 08.10.26 Aquestive Therapeutics Announces Positive Topline Human Factors and Pharmacokinetic Study Results for Anaphylm™ (dibutepinephrine) Sublingual Film Read More Events View all events Upcoming Events 09.14.26 9:00 AM EDT H.C. Wainwright 28th Annual Global Investment Conference 09.09.26 3:20 PM EDT 2026 Cantor Global Healthcare Conference Fireside Chat Past Events 08.12.26 8:00 AM EDT Q2 2026 Aquestive Therapeutics, Inc. Earnings Conference Call 05.14.26 8:00 AM EDT Q1 2026 Aquestive Therapeutics, Inc. Earnings Conference Call Presentations View all presentations Anaphylm Human Factors and Clinical Study Supplemental Materials Corporate Presentation – February 2026 1.8 MB Anaphylm™ (dibutepinephrine) Sublingual Film Complete Response Letter Supplemental Material 1.1 MB
08.11.26 Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update Read More
08.10.26 Aquestive Therapeutics Announces Positive Topline Human Factors and Pharmacokinetic Study Results for Anaphylm™ (dibutepinephrine) Sublingual Film Read More
